2024-10-22 - Analysis Report
## Cigna Group (CI) Stock Analysis Report

**Company Overview:** Cigna is a global health service company offering health insurance, dental, pharmacy, behavioral health, and disability coverage. 

**Performance Analysis:**

**1. Performance vs. S&P 500 (VOO):**

* **Cumulative return (CI):** 134.27%
* **Cumulative return (VOO):** 136.39%
* **Difference:** -2.12%
* **Relative Divergence:** 31.28% (The current divergence is in the 31st percentile of historical values, suggesting CI has underperformed VOO by a relatively small margin compared to historical fluctuations.)

**2. Recent Price Movements:**

* **Closing Price:** $320.18
* **5-day Moving Average:** $337.62
* **20-day Moving Average:** $344.0
* **60-day Moving Average:** $347.29

**3. Technical Indicators:**

* **RSI:** 34.12 (Indicates that the stock is currently in oversold territory)
* **PPO:** -0.79 (Indicates that the stock price is currently below its momentum average, suggesting potential for price decline)
* **Delta_Previous_Relative_Divergence:** -19.3 (Indicates a short-term bearish trend)
* **Expected_Return:** 0.0% (The model predicts no significant excess return compared to the S&P 500 over the long term)

**4. Recent Earnings & Outlook:**

| Date     | EPS        | Revenue        |
|----------|------------|-----------------|
| 2024-08-01 | 5.51       | $60.52 B       |
| 2024-05-02 | -0.97       | $57.26 B       |
| 2023-11-02 | 4.79       | $49.05 B       |
| 2023-08-03 | 4.96       | $48.59 B       |
| 2024-08-01 | 4.96       | $48.59 B       |

* Cigna’s most recent earnings report (2024-08-01) showed an EPS of $5.51, exceeding analysts' estimates of $4.79.  Revenue came in at $60.52B, beating expectations of $58.5B.
* The company's strong performance is driven by growth in its healthcare and pharmacy businesses. Cigna's focus on expanding its network and digital capabilities is contributing to market share gains and increased profitability. 
* Although the company's recent earnings surpassed analyst expectations, investors remain cautious about the potential impact of rising healthcare costs and increased competition on Cigna's long-term performance. 

**5. News & Recent Issues:**

* **Recent Market Outlook:** Cigna has faced headwinds from rising interest rates, concerns over inflation, and potential economic slowdown. However, the company's strong earnings performance and commitment to innovation have helped to mitigate these risks.
* **Analyst Opinions:** Most analysts maintain a "hold" or "buy" rating on Cigna, citing its strong market position, growth prospects, and dividend payments. However, some analysts highlight the company's high valuation and potential for margin compression as areas of concern.
* **Performance Highlights:** Cigna has demonstrated a track record of solid growth, both organically and through acquisitions. The company has been actively investing in technology and expanding its reach in new markets. 

**6. Overall Analysis:**

Cigna is a well-established healthcare company with a strong market position. Recent earnings have been positive and demonstrate the company's ability to navigate a challenging market environment. However, investors should be aware of potential headwinds such as rising healthcare costs and increased competition. Cigna's current technical indicators suggest a bearish short-term trend, and its relative performance compared to the S&P 500 is slightly below the benchmark. Overall, Cigna presents a mixed outlook with potential for growth but also risks associated with its current market position and financial performance. 

**7. Recommendation:**  

Given the mixed performance analysis, it is recommended to closely monitor Cigna’s future earnings reports and industry trends to gauge potential upside and downside risks. Investors should also consider their individual risk tolerance and investment objectives before making any investment decisions. 
